A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
Clinical trial NCT07671339 · RECRUITING
Trial details
- NCT number
- NCT07671339
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-22
- Primary completion
- 2028-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.